{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T18:32:51Z","timestamp":1778956371987,"version":"3.51.4"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T00:00:00Z","timestamp":1769644800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T00:00:00Z","timestamp":1769644800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1007\/s00520-026-10375-w","type":"journal-article","created":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T02:43:38Z","timestamp":1769654618000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Correlation between MASCC score and the evolution of febrile neutropenia in patients with solid tumors: a retrospective study"],"prefix":"10.1007","volume":"34","author":[{"given":"Charles-Eric","family":"Rivest","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatim Ezzahra","family":"Ben Abderrazik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc-Antoine","family":"C\u00f4t\u00e9-Marcoux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mandy","family":"Malick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catherine","family":"Allard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Hanel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michel","family":"Pavic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,29]]},"reference":[{"issue":"14","key":"10375_CR1","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1200\/JCO.2017.77.6211","volume":"36","author":"RA Taplitz","year":"2018","unstructured":"Taplitz RA, Kennedy EB, Bow EJ et al (2018) Outpatient management of fever and neutropenia in adults treated for malignancy: American Society of Clinical Oncology and Infectious Diseases Society of America clinical practice guideline update. J Clin Oncol 36(14):1443\u20131453. https:\/\/doi.org\/10.1200\/JCO.2017.77.6211","journal-title":"J Clin Oncol"},{"issue":"10","key":"10375_CR2","doi-asserted-by":"publisher","first-page":"2258","DOI":"10.1002\/cncr.21847","volume":"106","author":"NM Kuderer","year":"2006","unstructured":"Kuderer NM, Dale DC, Crawford J, Cosler LE, Lyman GH (2006) Mortality, morbidity, and cost associated with febrile neutropenia in adult cancer patients. Cancer 106(10):2258\u20132266. https:\/\/doi.org\/10.1002\/cncr.21847","journal-title":"Cancer"},{"issue":"16","key":"10375_CR3","doi-asserted-by":"publisher","first-page":"3038","DOI":"10.1200\/JCO.2000.18.16.3038","volume":"18","author":"J Klastersky","year":"2000","unstructured":"Klastersky J, Paesmans M, Rubenstein EB et al (2000) The Multinational Association for Supportive Care in Cancer risk index: a multinational scoring system for identifying low-risk febrile neutropenic cancer patients. J Clin Oncol 18(16):3038\u20133051. https:\/\/doi.org\/10.1200\/JCO.2000.18.16.3038","journal-title":"J Clin Oncol"},{"key":"10375_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2020.102922","volume":"149","author":"B Zheng","year":"2020","unstructured":"Zheng B, Toarta C, Cheng W et al (2020) Accuracy of the Multinational Association of Supportive Care in Cancer (MASCC) and Clinical Index of Stable Febrile Neutropenia (CISNE) scores for predicting serious complications in adult patients with febrile neutropenia: a systematic review and meta-analysis. Crit Rev Oncol Hematol 149:102922. https:\/\/doi.org\/10.1016\/j.critrevonc.2020.102922","journal-title":"Crit Rev Oncol Hematol"},{"issue":"10","key":"10375_CR5","doi-asserted-by":"publisher","first-page":"5905","DOI":"10.1007\/s00520-021-06154-4","volume":"29","author":"J Clark","year":"2021","unstructured":"Clark J, Sridhar A, Lagu T, Loh KP (2021) Use of MASCC score in the inpatient management of febrile neutropenia: a single-center retrospective study. Support Care Cancer 29(10):5905\u20135914. https:\/\/doi.org\/10.1007\/s00520-021-06154-4","journal-title":"Support Care Cancer"},{"key":"10375_CR6","unstructured":"MedCalc Software Ltd. Diagnostic test evaluation calculator. Available from:  https:\/\/www.medcalc.org\/calc\/diagnostic_test.php.\u00a0Accessed Mar 2025"},{"issue":"3","key":"10375_CR7","doi-asserted-by":"publisher","first-page":"37","DOI":"10.7812\/TPP\/14-188","volume":"19","author":"RA Bitar","year":"2015","unstructured":"Bitar RA (2015) Utility of the Multinational Association for Supportive Care in Cancer (MASCC) Risk Index Score as a criterion for nonadmission in febrile neutropenic patients with solid tumors. Perm J 19(3):37\u201347. https:\/\/doi.org\/10.7812\/TPP\/14-188","journal-title":"Perm J"},{"issue":"11","key":"10375_CR8","doi-asserted-by":"publisher","first-page":"e1600","DOI":"10.1200\/OP.21.00148","volume":"17","author":"DT Wijeratne","year":"2021","unstructured":"Wijeratne DT, Wright K, Gyawali B (2021) Risk-stratifying treatment strategies for febrile neutropenia\u2014tools, tools everywhere, and not a single one that works? JCO Oncol Pract 17(11):e1600\u2013e1605. https:\/\/doi.org\/10.1200\/OP.21.00148","journal-title":"JCO Oncol Pract"},{"issue":"1","key":"10375_CR9","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1200\/JOP.18.00269","volume":"15","author":"AJ Zimmer","year":"2019","unstructured":"Zimmer AJ, Freifeld AG (2019) Optimal management of neutropenic fever in patients with cancer. J Oncol Pract 15(1):19\u201324","journal-title":"J Oncol Pract"},{"issue":"23","key":"10375_CR10","doi-asserted-by":"publisher","first-page":"8475","DOI":"10.1002\/cam4.4355","volume":"10","author":"P Chaftari","year":"2021","unstructured":"Chaftari P, Chaftari AM, Hachem R et al (2021) The role of procalcitonin in identifying high-risk cancer patients with febrile neutropenia: a useful alternative to the Multinational Association for Supportive Care in Cancer score. Cancer Med 10(23):8475\u20138482. https:\/\/doi.org\/10.1002\/cam4.4355","journal-title":"Cancer Med"},{"issue":"15_suppl","key":"10375_CR11","doi-asserted-by":"publisher","first-page":"6102","DOI":"10.1200\/JCO.2010.28.15_suppl.6102","volume":"28","author":"O Teuffel","year":"2010","unstructured":"Teuffel O, Amir E, Sung L, Alibhai SM (2010) Treatment strategies for low-risk febrile neutropenia in adult cancer patients: a cost-utility analysis. J Clin Oncol 28(15_suppl):6102\u20136102. https:\/\/doi.org\/10.1200\/JCO.2010.28.15_suppl.6102","journal-title":"J Clin Oncol"},{"issue":"3","key":"10375_CR12","doi-asserted-by":"publisher","first-page":"e1345","DOI":"10.1002\/cnr2.1345","volume":"4","author":"M Nguyen","year":"2021","unstructured":"Nguyen M, Jacobson T, Torres J, Wann A (2021) Potential reduction of hospital stay length with outpatient management of low-risk febrile neutropenia in a regional cancer center. Cancer Reports (Hoboken) 4(3):e1345. https:\/\/doi.org\/10.1002\/cnr2.1345","journal-title":"Cancer Reports (Hoboken)"},{"issue":"4","key":"10375_CR13","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1200\/JCO.2007.13.8222","volume":"26","author":"LS Elting","year":"2008","unstructured":"Elting LS, Lu C, Escalante CP et al (2008) Outcomes and cost of outpatient or inpatient management of 712 patients with febrile neutropenia. J Clin Oncol 26(4):606\u2013611. https:\/\/doi.org\/10.1200\/JCO.2007.13.8222","journal-title":"J Clin Oncol"},{"key":"10375_CR14","unstructured":"Crespo A, Forbes L, Vu K, Gallo-Hershberg D, Enright K, Abdallah M et al. Prevention and outpatient management of febrile neutropenia in adult cancer patients: clinical practice guideline. Toronto (ON): Cancer Care Ontario; November 2021 [updated January 2022]. Available from: https:\/\/www.cancercareontario.ca\/en\/guidelines-advice\/types-of-cancer\/648. Accessed Apr 2025"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-026-10375-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00520-026-10375-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-026-10375-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T20:04:39Z","timestamp":1771272279000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00520-026-10375-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,29]]},"references-count":14,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["10375"],"URL":"https:\/\/doi.org\/10.1007\/s00520-026-10375-w","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-6606114\/v1","asserted-by":"object"}]},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,29]]},"assertion":[{"value":"6 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This retrospective study was conducted in accordance with the ethical standards of the Declaration of Helsinki and the Tri-Council Policy Statement (TCPS 2) for research involving humans. The project was approved by the Research Ethics Board of the CIUSSS de l\u2019Estrie\u2013CHUS (Nagano approval number: [2023-4793]), with a waiver of informed consent due to the retrospective nature of the study and minimal risk to participants. Ethical approval was granted based on the previously submitted and validated research protocol.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"141"}}